Prognostic Impact of C-Reactive Protein-to-Lymphocyte Ratio in Non-small Cell Lung Cancer: A Propensity Score-Matching Analysis

[1]  Y. Oda,et al.  Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma , 2021, International Journal of Clinical Oncology.

[2]  M. Bilici,et al.  The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer , 2020, Lung.

[3]  Yan Lu,et al.  The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis , 2020, PloS one.

[4]  Xianjun Yu,et al.  Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer , 2020, Annals of Surgical Oncology.

[5]  R. Ruiz-Cordero,et al.  Targeted Therapy and Checkpoint Immunotherapy in Lung Cancer. , 2020, Surgical pathology clinics.

[6]  C. Oldmeadow,et al.  Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). , 2019, Translational lung cancer research.

[7]  M. Murata.  Inflammation and cancer , 2018, Environmental Health and Preventive Medicine.

[8]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[9]  Jun Wu,et al.  Effect of C‐reactive protein/albumin ratio on prognosis in advanced non–small‐cell lung cancer , 2018, Asia-Pacific journal of clinical oncology.

[10]  A. Mantovani,et al.  Cancer Inflammation and Cytokines. , 2018, Cold Spring Harbor perspectives in biology.

[11]  W. Feleszko,et al.  Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review , 2018, International journal of environmental research and public health.

[12]  K. Schalper,et al.  Interleukin-8 in cancer pathogenesis, treatment and follow-up. , 2017, Cancer treatment reviews.

[13]  M. Netea,et al.  IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections , 2016, PLoS pathogens.

[14]  Ruth R. Montgomery,et al.  Age-dependent dysregulation of innate immunity , 2013, Nature Reviews Immunology.

[15]  Charles A Powell,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. , 2011, Proceedings of the American Thoracic Society.

[16]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  T. Kadowaki,et al.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity , 2009, Nature Medicine.

[18]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.